These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Failure of low molecular-weight heparin in the prevention of prosthetic mitral valve thrombosis during pregnancy: case report and a review of options for anticoagulation. Mahesh B; Evans S; Bryan AJ J Heart Valve Dis; 2002 Sep; 11(5):745-50. PubMed ID: 12358414 [TBL] [Abstract][Full Text] [Related]
23. Compliance with anticoagulant drug therapy: a study on patients with prosthetic heart valves. Howard AF; Frewin DB; Leonello PP; Taylor WB Med J Aust; 1981 Sep; 2(6):274-6. PubMed ID: 7300757 [TBL] [Abstract][Full Text] [Related]
24. Challenges in managing anticoagulant therapy in patients with heart valve prostheses. Vink R; Kamphuisen PW; van den Brink RB; Levi M Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678 [TBL] [Abstract][Full Text] [Related]
25. [Mitral and aortic valve replacement in childhood]. Berg T; Keck EW Z Kardiol; 1984 Mar; 73(3):173-80. PubMed ID: 6719995 [TBL] [Abstract][Full Text] [Related]
26. Management of anticoagulation in patients with prosthetic heart valves undergoing oral and maxillofacial operations. Webster K; Wilde J Br J Oral Maxillofac Surg; 2000 Apr; 38(2):124-6. PubMed ID: 10864707 [TBL] [Abstract][Full Text] [Related]
27. [Management of the prosthetic heart valve patient in clinical practice]. Roudaut R; Mignot A; Réant P; Lafitte S; Blanc P; Hervé D Rev Prat; 2009 Feb; 59(2):201-6. PubMed ID: 19317133 [TBL] [Abstract][Full Text] [Related]
28. [Use of low-molecular-weight heparins in patients with prosthetic heart valves]. Hering D; Horstkotte D Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904 [No Abstract] [Full Text] [Related]
29. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves. Bussey HI J Heart Valve Dis; 2004 May; 13(3):319-24. PubMed ID: 15222274 [TBL] [Abstract][Full Text] [Related]
34. Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves. Stefanidis A; Skafidas D; Papasteriadis E Eur Heart J; 2007 Oct; 28(20):2552-3; author reply 2553-4. PubMed ID: 17823214 [No Abstract] [Full Text] [Related]
35. Prosthetic heart valves: "perfection may be the enemy of good". Harken DE Med Instrum; 1977; 11(2):70-1. PubMed ID: 859471 [No Abstract] [Full Text] [Related]
36. Valvular heart disease: medical therapy and experimental and animal models. Johns JP; Bryg RJ Curr Opin Cardiol; 1993 Mar; 8(2):222-8. PubMed ID: 10148392 [TBL] [Abstract][Full Text] [Related]